Incidence of occult cervical metastasis in head and neck carcinomas: Development over time

Journal of Surgical Oncology

Volumn 107, Issue 4, 2013, Pages 384-387

  Psychogios, Georgios ^a   Mantsopoulos, Konstantinos ^a   Bohr, Christopher ^a   Koch, Michael ^a   Zenk, Johannes ^a   Iro, Heinrich ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

cervical metastases; elective treatment; head and neck cancer; N0 neck; neck dissection; occult metastases

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUTH CANCER; NECK DISSECTION; OROPHARYNX CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GERMANY; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; RETROSPECTIVE STUDIES;

EID: 84874259711     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23221     Document Type: Article

References (35)

1. Fasunla AJ, Greene BH, Timmesfeld N, et al.: A meta-analysis of the randomized controlled trials on elective neck dissection versus therapeutic neck dissection in oral cavity cancers with clinically node-negative neck. Oral Oncol 2011; 47: 320-324.
2. Rodrigo JP, Shah JP, Silver CE, et al.: Management of the clinically negative neck in early-stage head and neck cancers after transoral resection. Head Neck 2011; 33: 1210-1219.
3. Goudakos JK, Markou K, Nikolaou A, et al.: Management of the clinically negative neck (N0) of supraglottic laryngeal carcinoma: A systematic review. Eur J Surg Oncol 2009; 35: 223-229.
4. Weiss MH, Harrison LB, Isaacs RS:, Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 1994; 120: 699-702.
5. Iro H, Mantsopoulos K, Zenk J, et al.: Results of transoral laser resection in T1-2 oropharyngeal, hypopharyngeal and laryngeal carcinomas. Laryngorhinootologie 2011; 90: 481-485.
6. Psychogios G, Mantsopoulos K, Kuenzel J, et al.: Primary surgical treatment of T2 oropharyngeal carcinoma. J Surg Oncol 2012; 105: 719-723.
7. Takes RP, Rinaldo A, Rodrigo JP, et al.: Can biomarkers play a role in the decision about treatment of the clinically negative neck in patients with head and neck cancer ? Head Neck 2008; 30: 525-538.
8. Devaney KO, Rinaldo A, Ferlito A:, Micrometastases in cervical lymph nodes from patients with squamous carcinoma of the head and neck: Should they be actively sought? Maybe. Am J Otolaryngol 2007; 28: 271-274.
9. Richards PS, Peacock TE:, The role of ultrasound in the detection of cervical lymph node metastases in clinically N0 squamous cell carcinoma of the head and neck. Cancer Imaging 2007; 7: 167-178.
10. Ferlito A, Robbins KT, Shah JP, et al.: Proposal for a rational classification of neck dissections. Head Neck 2011; 33: 445-450.
11. Wei WI, Ferlito A, Rinaldo A, et al.: Management of the N0 neck-reference or preference. Oral Oncol 2006; 42: 115-122.
12. Pitman KT:, Rationale for elective neck dissection. Am J Otolaryngol 2000; 21: 31-37.
13. Okura M, Aikawa T, Sawai NY, et al.: Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncol 2009; 45: 908-911.
14. Rumboldt Z, Gordon L, Bonsall R, et al.: Imaging in head and neck cancer. Curr Treat Options Oncol 2006; 7: 23-34.
15. Lell M, Baum U, Greess H, et al.: Head and neck tumors: Imaging recurrent tumor and post-therapeutic changes with CT and MRI. Eur J Radiol 2000; 33: 239-247.
16. Ambrosch P, Kron M, Fischer G, et al.: Micrometastases in carcinoma of the upper aerodigestive tract: Detection, risk of metastasizing, and prognostic value of depth of invasion. Head Neck 1995; 17: 473-479.
17. Ferlito A, Rinaldo A, Devaney KO, et al.: Detection of lymph node micrometastases in patients with squamous carcinoma of the head and neck. Eur Arch Otorhinolaryngol 2008; 265: 1147-1153.
18. Ferlito A, Rinaldo A, Silver CE, et al.: Elective and therapeutic selective neck dissection. Oral Oncol 2006; 42: 14-25.
19. Teymoortash A, Hoch S, Eivazi B, et al.: Postoperative morbidity after different types of selective neck dissection. Laryngoscope 2010; 120: 924-929.
20. Olzowy B, Tsalemchuk Y, Schotten KJ, et al.: Frequency of bilateral cervical metastases in oropharyngeal squamous cell carcinoma: A retrospective analysis of 352 cases after bilateral neck dissection. Head Neck 2011; 33: 239-243.
21. Mantsopoulos K, Psychogios G, Waldfahrer F, et al.: Surgical treatment of locally limited tonsillar cancer. Surg Oncol 2012; 21: e13-e16.
22. Barrera JE, Miller ME, Said S, et al.: Detection of occult cervical micrometastases in patients with head and neck squamous cell cancer. Laryngoscope 2003; 113: 892-896.
23. Hoch S, Fasunla J, Eivazi B, et al.: Delayed lymph node metastases after elective neck dissection in patients with oral and oropharyngeal cancer and pN0 neck. Am J Otolaryngol 2012; DOI: 10.1016/j.amjoto.2011.11.005
24. Karatzanis AD, Psychogios G, Waldfahrer F, et al.: T1 and T2 hypopharyngeal cancer treatment with laser microsurgery. J Surg Oncol 2010; 102: 27-33.
25. El-Naaj IA, Leiser Y, Shveis M, et al.: Incidence of oral cancer occult metastasis and survival of T1-T2N0 oral cancer patients. J Oral Maxillofac Surg 2011; 69: 2674-2679.
26. Karatzanis AD, Psychogios G, Zenk J, et al.: Evaluation of available surgical management options for early supraglottic cancer. Head Neck 2010; 32: 1048-1055.
27. Markou K, Goudakos J, Triaridis S, et al.: The role of tumor size and patient's age as prognostic factors in laryngeal cancer. Hippokratia 2011; 15: 75-80.
28. Sparano A, Weinstein G, Chalian A, et al.: Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg 2004; 131: 472-476.
29. Pentenero M, Gandolfo S, Carrozzo M:, Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: A review of the literature. Head Neck 2005; 27: 1080-1091.
30. Karatzanis AD, Psychogios G, Mantsopoulos K, et al.: Management of advanced carcinoma of the base of tongue. J Surg Oncol 2012; DOI: 10.1002/jso.23135 [Epub ahead of print].
31. Tomifuji M, Imanishi Y, Araki K, et al.: Tumor depth as a predictor of lymph node metastasis of supraglottic and hypopharyngeal cancers. Ann Surg Oncol 2011; 18: 490-496.
32. Kovacs AF:, Head and neck squamous cell carcinoma: Sentinel node or selective neck dissection. Surg Oncol Clin N Am 2007; 16: 81-100.
33. Alkureishi LW, Ross GL, Shoaib T, et al.: Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial. Ann Surg Oncol 2010; 17: 2459-2464.
34. Schroeder U, Dietlein M, Wittekindt C, et al.: Is there a need for positron emission tomography imaging to stage the N0 neck in T1-T2 squamous cell carcinoma of the oral cavity or oropharynx ? Ann Otol Rhinol Laryngol 2008; 117: 854-863.
35. Keller F, Psychogios G, Linke R, et al.: Carcinoma of unknown primary in the head and neck: Comparison between positron emission tomography (PET) and PET/CT. Head Neck 2011; 33: 1569-1575.